|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
19
|
|
pubmed:dateCreated |
2010-6-29
|
|
pubmed:abstractText |
The activity of rituximab in pediatric B-cell non-Hodgkin's lymphoma (B-NHL) has not yet been determined. We conducted a phase II window study to examine activity and tolerability of rituximab in newly diagnosed pediatric B-NHL.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:AttarbaschiAndisheA,
pubmed-author:Berlin-Frankfurt-Münster group,
pubmed-author:BertholdFrankF,
pubmed-author:BorkhardtArndtA,
pubmed-author:BurkhardtBirgitB,
pubmed-author:Janka-SchaubGrittaG,
pubmed-author:KabickovaEditaE,
pubmed-author:KlapperWolframW,
pubmed-author:KleinChristophC,
pubmed-author:KlingebielThomasT,
pubmed-author:KontnyUdoU,
pubmed-author:MeinhardtAndreaA,
pubmed-author:ReiterAlfredA,
pubmed-author:SchrappeMartinM,
pubmed-author:ZimmermannMartinM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3115-21
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:20516455-Adolescent,
pubmed-meshheading:20516455-Antibodies, Monoclonal,
pubmed-meshheading:20516455-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:20516455-Antineoplastic Agents,
pubmed-meshheading:20516455-Burkitt Lymphoma,
pubmed-meshheading:20516455-Child,
pubmed-meshheading:20516455-Child, Preschool,
pubmed-meshheading:20516455-Fatigue,
pubmed-meshheading:20516455-Female,
pubmed-meshheading:20516455-Fever,
pubmed-meshheading:20516455-Humans,
pubmed-meshheading:20516455-Infant,
pubmed-meshheading:20516455-Infusions, Intravenous,
pubmed-meshheading:20516455-Lymphoma, B-Cell,
pubmed-meshheading:20516455-Lymphoma, Non-Hodgkin,
pubmed-meshheading:20516455-Male,
pubmed-meshheading:20516455-Nausea,
pubmed-meshheading:20516455-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia.
|
|
pubmed:affiliation |
Non-Hodgkin's Lymphoma-Berlin-Frankfurt-Münster Study Center, Justus Liebig University Giessen, Giessen, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
